Camellix Overview
- Year Founded
-
2011
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
Camellix General Information
Description
Developer of natural products using green tea technology designed to prevent viral infections. The company's green tea and epigallocatechin gallate are environmentally friendly, clinically tested personal care products based on botanical extracts, enabling users to get dry mouth relief and herpes treatment, and preventing viral infection by getting anti-oxidant, anti-inflammatory, anti-cancer, and anti-microbial effects.
Contact Information
Website
www.camellix.comCorporate Office
- 4106 Colben Boulevard
- Suite 101
- Evans, GA 30809
- United States
Corporate Office
- 4106 Colben Boulevard
- Suite 101
- Evans, GA 30809
- United States
Camellix Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 5. Grant | 01-Jul-2022 | Completed | Generating Revenue | |||
| 4. Grant | 30-Nov-2020 | Completed | Generating Revenue | |||
| 3. Grant | 01-Dec-2018 | Completed | Generating Revenue | |||
| 2. Grant | 30-Nov-2017 | $193K | Completed | Generating Revenue | ||
| 1. Early Stage VC | Completed | Startup |
Camellix Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| National Institute Of Allergy and Infectious Diseases | Government |
Camellix FAQs
-
When was Camellix founded?
Camellix was founded in 2011.
-
Where is Camellix headquartered?
Camellix is headquartered in Evans, GA.
-
What industry is Camellix in?
Camellix’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Camellix a private or public company?
Camellix is a Private company.
-
What is Camellix’s current revenue?
The current revenue for Camellix is .
-
Who are Camellix’s investors?
National Institutes of Health and National Institute Of Allergy and Infectious Diseases have invested in Camellix.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process